On Oct 24, major Wall Street analysts update their ratings for $Thermo Fisher Scientific (TMO.US)$, with price targets ranging from $610 to $718.
BofA Securities analyst Michael Ryskin maintains with a buy rating, and sets the target price at $675.
Barclays analyst Luke Sergott maintains with a hold rating, and maintains the target price at $610.
Wells Fargo analyst Brandon Couillard maintains with a buy rating, and adjusts the target price from $670 to $660.
Jefferies analyst Tycho Peterson maintains with a buy rating, and maintains the target price at $655.
TD Cowen analyst Daniel Brennan maintains with a buy rating, and maintains the target price at $686.
Furthermore, according to the comprehensive report, the opinions of $Thermo Fisher Scientific (TMO.US)$'s main analysts recently are as follows:
Thermo Fisher's recent quarterly report met expectations in a climate where anticipation was high. The company has demonstrated strong execution despite challenging conditions and uncertain timing for a demand resurgence in the tools sector.
The firm notes that Thermo Fisher's core growth is showing consistent improvement on a quarter-over-quarter basis, with projections hinting at a slight increase to approximately +2.5% in Q4. The expectations of a 5% core growth by 2025 also appear to be reasonable and justifiable. The firm expresses its preference for Thermo Fisher's resilient nature and the flexibility provided by its balance sheet.
The firm mentioned that Thermo Fisher presented a mixed set of results for the third quarter, with revenue falling just short of the general consensus but surpassing expectations on earnings. Management described the market conditions as matching their forecasts, with slight enhancements and steadiness observed throughout their range of offerings.
Here are the latest investment ratings and price targets for $Thermo Fisher Scientific (TMO.US)$ from 8 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美东时间10月24日，多家华尔街大行更新了$赛默飞世尔 (TMO.US)$的评级，目标价介于610美元至718美元。
美银证券分析师Michael Ryskin维持买入评级，目标价675美元。
巴克莱银行分析师Luke Sergott维持持有评级，维持目标价610美元。
富国集团分析师Brandon Couillard维持买入评级，并将目标价从670美元下调至660美元。
富瑞集团分析师Tycho Peterson维持买入评级，维持目标价655美元。
TD Cowen分析师Daniel Brennan维持买入评级，维持目标价686美元。
此外，综合报道，$赛默飞世尔 (TMO.US)$近期主要分析师观点如下：
Thermo Fisher最近的季度报告符合市场预期，尽管预期值较高。该公司在困难条件和需求在工具板块复苏的时机不确定的情况下，展现了强大的执行力。
该公司指出，Thermo Fisher的核心增长在季度基础上持续改善，预计第四季度将略微增长约+2.5%。到2025年，预期核心增长达到5%看起来也是合理且具备可信性的。公司表达了对Thermo Fisher坚韧性质和其资产负债表提供的灵活性的偏好。
该公司提到，Thermo Fisher在第三季度呈现了一套复杂的结果，营业收入略低于一般共识，但盈利超过预期。管理层描述市场状况与他们的预测相匹配，在他们的产品范围内观察到了轻微的改善和稳定。
以下为今日8位分析师对$赛默飞世尔 (TMO.US)$的最新投资评级及目标价：
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
